Wayland Enters the Asia-Pacific Market with Australian Acquisition
TORONTO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce its expansion into Australia, through entering into an agreement to acquire 50.1% of Tropicann Pty Ltd. (“Tropicann”), a newly formed, privately owned Australian company located in Darwin, Northern Territory, to partner with industry leaders in Australia’s expanding cannabis industry. With this acquisition Wayland has positioned itself in the important and burgeoning Asia-Pacific market.
“Globalization of cannabis continues, and we are present in relevant markets, with Asia-Pacific now added to our international footprint. The Northern Territory is the ideal location for our new Asia Pacific hub. The location provides Wayland with ideal climate conditions in a globally respected and sovereign country with a large and fast emerging market of over 250MM people just 4 hours north. This acquisition accelerates Wayland’s growth strategy in becoming a truly global cannabis company,” stated Wayland Chief Executive Officer Ben Ward.
Michael Gunner, the Chief Minister of the Northern Territory, declared, “We have a plan to diversify our economy and create jobs. Medicinal cannabis is a growth industry for the Northern Territory, particularly after its legalization by the Australian Government. The Northern Territory Government, Tropicann, and Wayland are in discussions about Major Project Status. Major Project Status ensures priority Ministerial oversight to assist with ongoing project coordination and facilitation across different government agencies to secure timely project delivery.”
“This is a very real and exciting opportunity for the people of the Northern Territory to enter and participate in a new growth sector in the global economy. It also offers the possibility of creating value-added products through processing here in the Northern Territory,” stated Ken Vowles, Minister for Primary Industry and Resources.
Pursuant to the terms of the agreement the Company has agreed to make an initial payment of $4,800,000 Canadian dollars (“CAD”) followed by a second payment of $24,000,000 CAD following certain milestones being achieved, including issuance to Tropicann of a license to cultivate cannabis in Australia.
Both payments will be satisfied by the issuance of common shares of the Company based on then-current market prices, but subject to a floor issue price of $1.65 per common share.
The payments are conditional on receipt of applicable stock exchange approval, approval of holders of at least two-thirds of the Company's outstanding debentures and any other applicable approvals.
Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.
About Wayland Group
Wayland is a vertically integrated producer and distributor of cannabis for medical purposes. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland.
Forward Looking Statements
This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the completion of the proposed acquisition and the plans for the assets of the entities being acquired, its plan to achieve EU-GMP production standards in its German operations and GACP standards in all international cultivation operations and the plan to create a reliable and consistent mass supply of cannabinoid isolates for the global market. As noted above completion of the transactions are subject to a number of conditions and there is no certainty that either transaction will be completed on the terms set forth in this press release or at all. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
For more information about Wayland, please visit our website at www.waylandgroup.com
Contact Information: Investor Relations Graham Farrell VP, Communications Graham.Farrell@waylandgroup.com 647-643-7665
Media Inquiries: email@example.com
Corporate Headquarters (Canada) Wayland Group Corp. (Toronto) 845 Harrington Court, Unit 3 Burlington Ontario L7N 3P3 Canada 289-288-6274 European Headquarters (Germany) Maricann GmbH Thierschstrasse 3, 80538 Munchen, Deutschland